The content of this website has been produced in line with the BOSULIF®▼ (bosutinib) Summary of Product Characteristics for Great Britain and is intended for Healthcare Professionals based in Great Britain. BOSULIF▼ Prescribing Information for Great Britain and for Northern Ireland, and adverse event reporting information can be found at the bottom of the page.
In this video, Richard discusses:
Richard Clark is Professor of Haematology at the University of Liverpool, UK. He studied medicine at Cambridge and Westminster Medical School, London, and, after his junior posts, co-established myeloid leukaemia research at Cardiff with Professor Allan Jacobs, as a research fellow and later Senior Lecturer. He moved to Liverpool in 1990 as Senior Lecturer and Consultant Haematologist and Director of the Regional Bone Marrow Transplant (BMT) programme at Royal Liverpool University Hospital.
Professor Clark’s research interests over the past 30 years have been in myeloid leukaemias, especially chronic myeloid leukaemia (CML). He is the chief or principal investigator for numerous trials in both acute leukaemia and myeloid malignancies and most recently the lead and chief investigator of one of the largest UK-wide study of discontinuation of TKIs in CML.
Compare 2013 guidelines to those published in 2020
Hear Dr. Alex Lyon’s views on long-term TKI treatment in an ageing patient population video
For Great Britain
Bosulif (bosutinib) Prescribing Information - 100mg Tablets
Bosulif (bosutinib) Prescribing Information - 400mg Tablets
Bosulif (bosutinib) Prescribing Information - 500mg Tablets
For Northern Ireland
Bosulif (bosutinib) Prescribing Information
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. March 2021
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020